Non-invasive glucose monitoring: Failures and hopes;Unblutiges glukosemonitoring: Enttäuschungen und hoffnungen

Diabetes, Stoffwechsel und Herz

Volumn 15, Issue 4, 2006, Pages 55-66

  Thomas, Andreas ^a   Heinemann, L ^b  

^a DIA REAL GmbH   (Germany)

^b PROFIL Institut für Stoffwechselforschung   (Germany)

Author keywords

Continuous glucose monitoring; Glucose sensors; Physical and chemical possibilities

Indexed keywords

GLUCOSE;

BLOOD GLUCOSE MONITORING; CHEMICAL METHOD; DIABETES MELLITUS; DIAGNOSTIC TEST; GLUCOSE TRANSDUCER; HUMAN; NON INVASIVE PROCEDURE; PHYSICAL METHOD; REVIEW; TECHNIQUE;

EID: 57349185599     PISSN: 18617603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Poletaew D, Renner R, Hepp KD: Sind in der Behandlung Typ-1-diabetischer Patienten (T1D) graphische Blutzuckerprotokolle vorteilhafter als tabellarische? Diab Stoffw 1996; 5 (Suppl 1): 121
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 14: 977-986
3. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983
4. Kadish AH: Automation control of blood sugar a servomechanism for glucose monitoring and control. Trans Am Soc Artif Intern Organs 1963; 9: 363-367
5. Albisser AM, Leibel BS, Eward TG, Davidovac Z, Botz CK, Zingg W: An artifical endocrine pancreas. Diabetes 1974; 23 (5): 389-396
6. Albisser AM, Leibel BS, Zinman B, Murray FT, Zingg W, Botz CK, Denoga A, Marliss EB: Studies with an artifical endocrine pancreas. Arch Intern Med 1977; 137 (5): 639-649
7. Pfeiffer EF: On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. Diabetologia 1987; 30 (2): 51-65
8. Babitsky G, Fine I, Coslovsky R, Shpigelman E, Knobler H: Occlusion-Assisted Non-Invasive Blood Glucose Monitoring in the NIR Using Individual Calibration. Diabetes 2001; 50 (Suppl 2): A105
9. March WF, Smith FE, Herbrechtsmeier P, Domschke A, Morris C: Clinical Trial of a Non-Invasive Ocular Glucose Sensor. Diabetes 2001; 50 (Suppl 2): A125
10. Ok Kyung C, Yoon Ok K, Hiroshi M, Katsuhiko K: Noninvasive Measurement of Glucose by Metabolic Heat Conformation Method. Clinical Chemistry 2004; 50: 1894-1898
11. Hayashi Y, Livshits L, Caduff A, Feldman Yu: Dielectric spectroscopy study of specific glucose reaction on erythrocyte membranes. J Phys D 2003; 36: 369-374
12. Feldman Yu, Ermolina, I, Hayashi Y: Time Domain Dielectric Spectroscopy Study of Biological Systems. IEEE Transactions on Dielectrics and EI. 2003; 10 (5): 728-775
13. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ: Physiological Differences between Interstitial Glucose and Blood Glucose Measured in Human Subjects. Diabetes Care 2003; 26: 2405-2409
14. http://www.minimed.com/products/guardianrt/index.html
15. Deiss D, Phillip M, Batterlino T, Bosi E, Kerr D, Riveline JP, Tubiana-Rufi N, Bolinder: First Experience Using the Guardian®RT Continuous Glucose Monitoring System with Real-Time Values and Alerts in T1DM Patients: Results of a Pilot Study. Diabetes 2005; 54 (Suppl 1): A97
16. Wang L: An Engineering Analysis of Guardian Continuous Glucose Monitoring System Alerts. Diabetes 2005; 54 (Suppl 1): A100
17. http://abbottdiabetescare.com/freestylenavigator/qa.aspx
18. http://www.dexcom.com/
19. Jovanovic L, Zisser H, Schwartz S, Bailey R, Kaplan R: Randomized Controlled Study of a Transcutaneous, Real-Time Continuous Glucose Sensor Demonstrates Improvement in Glycemic Control. Diabetes 2005; 54 (Suppl 1): Appendix
20. http://www.isensecorp.com/
21. Heinemann L, Rave K, Kronshage B, Ward K, Sass D, Essenpreis M, Voelkel D, Lodwig V: Glukose-Monitoring über 5 Tage bei Typ 1 Diabetikern mit einem neuartigen Glukose-Sensor. Diab Stoffw 2005; 14: 112
22. Fahry LS, Kovatchev BP, Gonder-Frederick LA, Cox DJ, Anderson MS, Clarke WL: First Experience Using the Guardian®RT Accuracy of FreeStyle Navigator™ and MiniMed CGMS® during Euglycemia and Induced Hypoglycemia. Diabetes 2005; 54 (Suppl 1): A97
23. Jungheim K, Wientjes KJ, Heinemann L, Lodwig V, Koschinsky T, Schoonen AJ: Subcutaneous Continuous Glucose Monitoring: Feasibility of a new microdialysis-based glucose sensor system. Diabetes Care 2001; 24: 1696-1697
24. Maran A., Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous Subcutaneous Glucose Monitoring in Diabetic Patients: A multicenter analysis. Diabetes Care 2002; 25: 347-352
25. Dimitriadis G, Karamountzos, A, Triaridis N, Raptis A, Hatziagelaki E, Raptis SA:Continuous monitoring of subcutaneous glucose levels with GlucoDay: comparison with the reference hexokinase method and the BiostatorR. Diabetes Metabol 2003; 29: 4S194
26. Burdick JP, Chase HP, Fiallo-Scharer R, Faupel M, Wangness M, Gebhart S: Optimization of the SpectRx Continuous Glucose Monitoring System (SCGMS) in Pediatric Patients with Type 1 Diabetes. Diabetes 2003; 52 (Suppl 1): A90
27. Edelman SV, Schwartz S, Garg SK: Glucose profiles in patients implanted with a real-time, long-term, glucose sensor. Diabetes 2003; 52 (Suppl 1): Appendix
28. Scott R, Morrison Z, Garg S: Reduced Exposure to Hyperglycemia and Decreased Risk of Hypoglycemic Events in Patients with Type 1 Diabetes Using a Long-Term Continuous Glucose Sensor. Diabetes 2004; 53 (Suppl 2): Appendix
29. Renard E, Costalat G, Moran B, Shah R, Zhang Y, Villegas D, Kolopp M, Lebel R, Bringer J: First Combined Implantations of a Long-Term IV Glucose Sensor and an Intra-Peritoneal Insulin Pump in Diabetic Patients. Diabetes 2001; 50 (Suppl 2): A3
30. Renard EM, Shah R, Miller M, Kolopp M, Costalat G, Bringer J: Sustained safety and accuracy of central IV glucose sensors connected to implanted insulin pumps and short-term closed-loop trials in diabetic patients. Diabetologia 2003; 46 (Suppl 2): A47
31. Hendee S, Way J, Nguyen C, Fleming C: Technical Feasibility of Using NIR Spectroscopy for Continuous Blood Glucose Monitoring. Diabetes 2005; 54 (Suppl 1): Appendix
32. Kristensen JS: Trans-Cutaneous Fluorescence Lifetime Based Continuous Glucose Reading for Long Term Interrogation. Diabetologia 2005; 48 (Suppl 1): A49
33. www.glucon.com
34. Raz I, Wainstein J, Argaman D: Continuous Non Invasive Venous Blood Glucose Monitor. Diabetes 2003; 52 (Suppl 1): A98
35. http://www.integrity-app.com
36. http://www.sangui.de/
37. http://www.glucowatch.com
38. Beyer U, Schäfer D, Thomas A, Aulich H, Haueter U, Reihl B, Ehwald R: Recording of subcutaneous glucose dynamics by a viscometric affinity sensor. Diabetologia 2001; 44: 416-423
39. Rylander E, Nilsson K, Karlén M, Berger B: Continuous glucose monitoring - results and therapeutic implications from 3,000 hours registration. Diabetes Metabol 2003; 29: 4S193
40. 1c with Less Hypoglycemia Than Blood Glucose Meter Data Alone. Diabetes 2003; 52 (Suppl 1): A90
41. Sibenaler A, Boullu-Sanchis S, Jeandidier N, Pinget M, Meyer L: Detection of Hypoglycemia with the Continuous Glucose Monitoring System. Diabetes 2003; 52 (Suppl 1): A99
42. Thorsteinsson B, Pramming S, Pedersen-Bjergaard U: The Influence of Risk Factors on Hypoglycemia in Type 1 Diabetes Assessed by Continuous Subcutaneous Glucose Monitoring. Diabetes 2003; 52 (Suppl 1): A149
43. Bondy L, Tildesley H, Robinson C, Pottinger B, Bebb R, Gill S, Kreisman S, Mase R: The clinical utility of the continuous glucose monitoring system in the treatment of diabetes Type 1 and 2 patients. Diabetes Metabol 2003; 29: 4S195
44. Shin J, Mastrototaro J, De Leon R, Van Antwerp B, Fredrickson L: What Is Normal Glycemic Control? Diabetes 2003; 52 (Suppl 1): A99
45. Goldner WS, Kraus VL, Hunter SK, Sivitz WI, Dillon JS: Continuous Glucose Monitoring during Multiple Menstrual Cycles Shows Stable Patterns of Blood Glucose Control in Individual Women with Type 1 Diabetes. Diabetes 2003; 52 (Suppl 1): A94
46. Vasquez-Solomom S, Fridamn CL, Florez HJ, Mintz DH, Meneghin LF: Use of Continuous Glucose Monitoring for Screening Women at Risk for Gestational Diabetes Mellitus (GDM). Diabetes 2003; 52 (Suppl 1): A100
47. Kalmovich B, Hauptman E, Stern I, Raz I, Wainstein J: Continuous glucose monitoring in cardiac surgery. Diabetes Metabol. 2003; 29: 4S196
48. Kaisermann K, Halvorson M, Gudmundsson M, Carpenter S, Conrad B: Use of CGMS in Diabetes Education to Optimize Glycemic Control with Prolonged Physical Exercise. Diabetes 2003; 52 (Suppl 1): A208
49. Petersen B, Schweitzer MA, Peiker J, Richter M, Zick R: Comparison of Continuous Blood Glucose Measurement with Conventional Documentation of Hypoglycemia in Patients with Type 2 Diabetes on Multiple Daily Insulin Injection Therapy. Diabetes 2005; 54 (Suppl 1): A492
50. Jendrike N, Patte C, Buck H, Haug C, Freckmann G: Hypoglycemia Detection with Continuous Tissue Glucose Monitoring. Diabetes 2005; 54 (Suppl 1): A99
51. Wang L: An Engineering Analysis of Guardian Continuous Glucose Monitoring System Alerts. Diabetes 2005; 54 (Suppl 1): A100
52. Klonoff CD: Continuous Glucose Monitoring Roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239